TRT|RTR rulez? Really? [RSABE / ABEL]

posted by d_labes  – Berlin, Germany, 2013-08-14 10:16 (4292 d 13:12 ago) – Posting: # 11275
Views: 10,119

Dear Dan, ElMaestro and Helmut!

Rulez? Really?
Read chapter 9.3 of Chow and Liu, especially 9.3.4 "Assessment of Intra-Subject Variabilities". And if you have, read it again.

For me the consequence of this chapter is: While it is true that this design has the advantage of allowing the separate estimation of the intra-subject variabilities of Reference and Test, there is no valid way to evaluate T versus R in case of heteroscedasticity. And this renders the advantage useless.

A valid evaluation with GLM-ANOVA or even with intra-subject contrasts, which in other replicate designs is able to deal with different variabilities, has to assume s2wT=s2wR.

If this is also the case for evaluation via mixed model software is left for discussion. But at least in the EMA jurisdiction doesn't allow for it if we take the Q&A literally and translate 'not recommended' into 'not allowed'.

❝ BTW, if you like a reference that’s a design the two Lászlós used in some of their papers / simulations.


Which one do you mean?

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
123 visitors (0 registered, 123 guests [including 71 identified bots]).
Forum time: 23:28 CEST (Europe/Vienna)

Don’t undertake a project
unless it’s manifestly important
and nearly impossible.    Edwin H. Land

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5